Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any bronchiectasis in which the cause of the disease is a mutation in the SCNN1G gene.
Features include: Bronchiectasis and Chronic bronchitis.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Bronchiectasis, Chronic bronchitis |
SCNN1G function has not been fully characterized.
Bronchiectasis with or without elevated sweat chloride 3 is associated with mutations in the SCNN1G gene on chromosome 16.
Genetic testing for SCNN1G is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for bronchiectasis with or without elevated sweat chloride 3 has been reported in the published literature.
No clinical trials have been registered for bronchiectasis with or without elevated sweat chloride 3.
202 publications have been identified in PubMed for bronchiectasis with or without elevated sweat chloride 3. Kisho has analyzed 124 by research type. Research spans Clinical Trial Publication (26%), Epidemiology / Natural History (25%), and Review / Meta-Analysis (24%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 32 | 26% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:55 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Disease patterns and progression |
31 |
25% |
Research summaries | 30 | 24% |
Laboratory research | 14 | 11% |
Other research | 7 | 6% |
Testing and diagnosis research | 6 | 5% |
New treatment approaches | 3 | 2% |
Patient case studies | 1 | 1% |
Bautista J (2026). [PMID: 41593454](https://pubmed.ncbi.nlm.nih.gov/41593454/). *Current opinion in infectious diseases*. [Review / Meta-Analysis]
Pan Y (2026). [PMID: 42051198](https://pubmed.ncbi.nlm.nih.gov/42051198/). *Ther Adv Respir Dis*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Review / Meta-Analysis]
Gramegna A (2026). [PMID: 41527769](https://pubmed.ncbi.nlm.nih.gov/41527769/). *Pulmonology*. [Epidemiology / Natural History]
Huang RL (2025). [PMID: 39778078](https://pubmed.ncbi.nlm.nih.gov/39778078/). *Pediatric pulmonology*. [Diagnostic / Biomarker]
Chalmers JD (2025). [PMID: 40639876](https://pubmed.ncbi.nlm.nih.gov/40639876/). *The European respiratory journal*. [Case Report / Case Series]
Maselli DJ (2025). [PMID: 40047208](https://pubmed.ncbi.nlm.nih.gov/40047208/). *Current opinion in pulmonary medicine*. [Clinical Trial Publication]
Pollock J (2025). [PMID: 39461553](https://pubmed.ncbi.nlm.nih.gov/39461553/). *Chest*. [Clinical Trial Publication]
Johnson ED (2025). [PMID: 39938076](https://pubmed.ncbi.nlm.nih.gov/39938076/). *American journal of respiratory and critical care medicine*. [Basic Science / Preclinical]
Guo R (2025). [PMID: 39603670](https://pubmed.ncbi.nlm.nih.gov/39603670/). *The European respiratory journal*. [Clinical Trial Publication]